FDA approves Roche's real-time PCR COBAS TaqMan HCV Test, v2.0

Oct 25 2010NewsGuard 100/100 Score

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food & Drug Administration (FDA) has approved the real-time PCR COBAS® TaqMan® HCV Test, v2.0. Clinical research organizations have depended on COBAS® TaqMan® technology to support hepatitis C pharmaceutical trials and development. This new test will help clinicians to more confidently and effectively monitor their patients, and to improve treatment outcomes.

"This HCV quantitative test is key to measuring the effectiveness of many antivirals that are currently in clinical development for the treatment of hepatitis C," said Teresa Wright, M.D., Chief Medical Officer of Roche Molecular Diagnostics. "Roche is committed to providing complete diagnostic and treatment solutions for this important global disease."

Source:

Roche

Posted in: Device / Technology News | Disease/Infection News

Tags: , , , , , , , , , , , , , , , , , , , , , , ,

Comments (0)

Suggested Reading

High levels of microplastics found in prostate tumors, possibly linked to take-out food
Liver receptor mutations linked to liver dysfunction, cholesterol accumulation, and hepatitis
Online food shopping: Are you getting the information you need?
Ultra-processed food linked to weight gain and lower well-being in adolescents
Not all ultra-processed foods are made alike: Researchers warn against villainizing entire food group
Six common flying with food allergies myths
Key triggers for food allergies in children after organ transplants
Updated Food Compass 2.0 improves food health ratings using new diet data

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
(Logout)
Post

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback

You might also like...
Ultra-processed foods dominate children's diets from toddlerhood to middle childhood